![Jesse Boehm Profile](https://pbs.twimg.com/profile_images/1364926546394374152/FlA6sdPZ_x96.jpg)
Jesse Boehm
@boehmjesse
Followers
2K
Following
72
Statuses
2K
Chief Science Officer, Break Through Cancer; Principal Investigator: https://t.co/XI1QrUIt95 @ Koch Institute, MIT
Cambridge, MA
Joined September 2012
RT @break_cancer: Our CSO, @boehmjesse, delivers the closing keynote at #slas2025 today—reflecting on a decade of lab science innovation, t…
0
2
0
RT @break_cancer: We are excited to have launched an expanded Phase 1 trial cohort for pancreatic cancer with Revolution Medicines. This tr…
0
4
0
RT @SchenkLab: Thrilled to be part of the Lung TeamLab and the incredible collaboration to eliminate residual disease!
0
2
0
RT @vincentlamMD: Honored to be part of this #radicalcollaboration to advance cures in ALK+ and other lung cancers. Let's go!! @break_cance…
0
5
0
RT @christine_lovly: Tackling big problems requires radical collaboration 💪. The “PoweRD 2 Cure” team strives to overcome minimal residual…
0
12
0
RT @ALKPositiveinc: Our vision is a world in which ALK+ cancer is a curable disease. Proud to be supporters of @break_cancer’s bold initiat…
0
6
0
RT @VUMC_Cancer: We are thrilled to be part of the PoweRD 2 Cure ALK+ Lung Cancer TeamLab! This dynamic collaboration aims to make signific…
0
3
0
RT @CUCancerCenter: Shoutout to CU Cancer Center members Erin Schenk (@SchenkLab), MD, PhD, D. Ross Camidge (@DRCamidge), MD, PhD, and thei…
0
6
0
RT @break_cancer: Lung cancer relapse is fueled by cells that evade treatment. Our new PoweRD 2 Cure ALK+ Lung Cancer TeamLab is focused on…
0
6
0
RT @break_cancer: Today we launch the PoweRD 2 Cure ALK+ Lung Cancer TeamLab! Uniting researchers from @DanaFarber @MDAndersonNews @kochin…
0
12
0
Looking forward to delivering keynote address at the #slas2025 meeting January 25 - 29, 2025 (San Diego). I will share thoughts on current and future state of precision functional genomics to drive precision medicine forward. San Diego sunshine guaranteed!
0
0
6
RT @break_cancer: Break Through Cancer welcomes Dr. Marina Konopleva to our Eradicating Minimal Residual Disease in AML TeamLab. Dr. Konopl…
0
2
0
RT @break_cancer: Celebrating Lauren Brais of @DanaFarber recipient of the David M. Livingston Collaboration Award! This award honors those…
0
1
0
RT @DanielleHammo20: Wonderful advance for patients!!! Shoutout to @GhayasIssa @CuglievanBranko @DrHKantarjian and so many more @MDAnderson…
0
4
0
RT @break_cancer: We are proud to recognize Dr. Andrew A. Lane of @DanaFarber with the David M. Livingston Collaboration Award. This award…
0
7
0
RT @break_cancer: We are honored to present Lisa Schwarz with the inaugural Break Through Cancer Founders Award, celebrating her unwavering…
0
1
0
RT @BettyKimLab: The absolute best-in-class #mentors and #sponsors one could ever ask for. Thank you for dropping by @break_cancer #summ…
0
1
0
RT @Aiims1742: I can’t stop looking at the scans of the young patients with DIPG who responded so well to the GD2 CAR-T cells. Small number…
0
14
0